Collapse/Expand Please follow the link below if floor plan does not appear Exhibition Floor Plan

Space # Company/Organisation   Space # Company/Organisation
121 PURPLE DAY JAPAN   422 Persyst Development Corp.
123 Neuroventis   423 Stoke Therapeutics
124 NightWatch Epilepsy Detection   424 X-System
211 Angelini Pharma   431 Compumedics Europe GmbH
212 ILAE Sections - Neurotech & Pharmacy   432 Neuraxpharm
213 ILAE Nursing Section   433  
222 UNEEG medical   434 Brainlab
223 Natus   435 DIXI medical
224 vCreate   436 BESA GmbH
225 BioSerenity, Inc.   441 Desitin Arzneimittel GmbH
226 encevis   521 Takeda
311 Jazz Pharmaceuticals   522 ILAE YES
321 Biocodex   523 Wisepress Medical Bookshop
323 Biohaven   N1 Matthew's Friends
331 Epilog   N2 Future Neuro
332 MEDTRONIC   N3 BPNA (British Paediatric Neurology Association)
333 EB Neuro S.p.A.   N4  
334 Kephala Ltd.   N5 Dravet Syndrome Ireland
335     N6 Dravet Syndrome UK
336 MEGIN   N7 Young Epilepsy UK
341 ASET - Neurodiagnostic Society   N8 ESNA (Epilepsy Specialist Nurses Association)
342 ABRET Neurodiagnostic Credentialing and Accreditation   N9 SynGAP Research Fund Europe  
343 ERN EpiCare   N10 Ring20 Research and Support 
411 UCB   N12 European Academy of Neurology (EAN)
412 LivaNova   N13 Anita Kaufmann Foundation
421 Ad-Tech Medical Instrument Corporation      


Exhibition Opening Hours

3 September 09:00-17:30
4 September 09:00-17:30
5 September 09:00-17:30


Exhibition Booking Form (SOLD OUT!)
Collapse/Expand Please follow the link below if floor plan does not appear Exhibition Booking Form


Invitation to Industry

For details on all items available to ILAE's industry partners at IEC 2023, please consult the invitation to industry:

IEC 2023 Invitation to Industry


Major Partners       Partner
Jazz Pharmaceuticals
Angelini Pharma




Stoke Therapeutics
Longboard Pharmaceuticals


UNEEG medical
Ad-Tech Medical Instrument Corporation
Compumedics Europe GmbH
EB Neuro S.p.A.
Persyst Development Corp.
BioSerenity, Inc.
DIXI medical
NightWatch Epilepsy Detection
Purple Day Japan
Kephala Ltd.


Scientific Exhibits
Organiser UCB
Time & Date 09:00-17:30, Sunday-Tuesday, 3-5 September 2023
Location Poster Area


Satellite Symposia
Time & Date 08:00-09:30, Sunday, 3 September 2023
Location Liffey Hall 2
Chair Norman Delanty (Ireland)
Presentation 1 Adam Strzelczyk (Germany): Impact of epilepsy and antiseizure medications on the quality of life in people with epilepsy
Presentation 2 Michael Kinney (UK) and Seán Slaght (UK): When to consider switching to adjunctive antiseizure medications and importance of individualising treatment decisions
Presentation 3 Vicente Villanueva (Spain): Perampanel as an early adjunctive treatment: data from the PERMIT study

This promotional meeting is organised and funded by Jazz Pharmaceuticals for healthcare professionals only.

Time & Date 13:45-15:00, Sunday, 3 September 2023
Location Wicklow Hall 2
Chair Peter Widdess-Walsh (Ireland)
Presentation 1 Peter Widdess-Walsh (Ireland): Setting the scene: Understanding the complexity of developmental and epileptic encephalopathies (DEEs)
Presentation 2 Kerstin Alexandra Klotz (Germany): A whole-patient approach to DEE management: A paediatric neurologist's perspective
Presentation 3 Peter Widdess-Walsh (Ireland): Are DEEs for adult neurologists too?
Presentation 4 Antonietta Coppola (Italy): A whole-patient approach to DEE management: An adult neurologist's perspective
Panel Discussion Navigating clinical challenges through best practice sharing
Presentation 5 Peter Widdess-Walsh (Ireland): Summary

Jazz Pharmaceuticals’ product(s) will be discussed in line with the EU Marketing Authorisation. Prescribing Information and adverse event reporting information is available at this meeting.

INT-EPX-2300057 | August 2023

Time & Date 17:00-18:30, Sunday, 3 September 2023
Location Wicklow Hall 2
Chair Cristina Ruedell Reschke (Ireland)
Presentation 1 Eugen Trinka (Austria) & Nicolas Gaspard (Belgium): How long is too long in seizure emergencies?
Presentation 2 Nicolas Gaspard (Belgium): Early intervention in adult seizure emergencies: A case-led discussion
Presentation 3 Jesus Eric Pina-Garza (USA): Early intervention in pediatric seizure emergencies: A case-led discussion
Presentation 4 Jesus Eric Pina-Garza (USA) & Eugen Trinka (Austria): The Seizure Termination Project – an expert consensus on seizure emergencies
Time & Date 08:00-09:30, Monday, 4 September 2023
Location Wicklow Hall 2
Chair Norman Delanty (Ireland)
Presentation 1 Rima Nabbout (France): Bringing excellence from presentation to transition
Presentation 2 Sanjay Sisodiya (UK): Bridging the gaps – navigating to adulthood and addressing misdiagnosis
Presentation 3 Adam Strzelczyk (Germany): Balancing treatments goals and family priorities for adult patients
Time & Date 13:45-15:00, Monday, 4 September 2023
Location Wicklow Hall 2
Chair Patrick Kwan (Australia)
Presentation 1

Patrick Kwan (Australia):

1.Patient Experience while waiting for seizure freedom study 

2.Current landscape: 30 years without change

Presentation 2

Manuel Toledo (Spain):

1.Clinical perspectives from Session 1 

2.Quality and quantity of life 

Presentation 3 Norman Delanty (Ireland): The super-refractory patients
Presentation 4 Rhys Thomas (UK): The Newcastle experience: From EAP to real-world 
Time & Date 17:00-18:15, Monday, 4 September 2023
Location Liffey Hall 1
Chair Emily C. de los Reyes (USA)
Presentation 1 Pasquale Striano (Italy): Uncovering the genetic cause of paediatric epilepsy – the first step...
Presentation 2 Emily C. de los Reyes (USA): targeted disease management – enlightening insights from a clinical case study
Time & Date 08:00-09:30, Tuesday, 5 September 2023
Location Liffey Hall 2
Chair Scott Perry (USA)
Presentation 1 Ingrid Scheffer (Australia): Making an Early Diagnosis of Dravet Syndrome is Crucial
Presentation 2 Elaine Wirrell (USA): Early Life DEEs –How Does Defining Syndromes and Etiology Help with Management?
Presentation 3 Antonio Gil-Nagel (Spain): Dravet Syndrome: Moving Beyond Seizures, Treating the Non-seizure Comorbidities
Presentation 4 Scott Perry (USA): Treatment Outcomes of STK-001 for the Treatment of Dravet Syndrome
Time & Date 13:45-15:00, Tuesday, 5 September 2023
Location Liffey Hall 2
Chair Susanne Schubert-Bast (Germany)
Presentation 1 Pasquale Striano (Italy): Early genetic testing in Dravet syndrome: why, when, how
Presentation 2 Susanne Schubert-Bast (Germany): Giving diagnosis to caregiver – First data of a Delphi consensus study
Presentation 3 Francesca Darra (Italy): Dravet Syndrome from a cognitive and neurodevelopmental point of view – Linking early management and outcomes
Time & Date 17:00-17:45, Tuesday, 5 September 2023
Location Liffey Hall 2
Chair David Wright (United Kingdom)
Presentation 1 David Wright (United Kingdom): The importance of formulation

Sándor Beniczky (Denmark)
Stefan Rampp (Germany)

Part 1 (Theory) Monday, 4 September 2023, 08:00-09:30, Liffey Meeting Room 2
Part 2 (Hands-On) Tuesday, 5 September 2023, 08:00-09:30, Liffey Meeting Room 2

Please note: Parts 1 and 2 (Theory and Hands-On) require a registration add-on to participate. No spaces are available. Participants can avail of the free trial software installation which should be installed on their deivce prior to Tuesday, 5 September at space #436 in the exhibition area.

Congress Begins

263Days : 10Hours : 15Minutes : 33Seconds

Key Dates

Congress begins

2 September, 2023

Subscribe to the ILAE Newsletter

To subscribe, please click on the button below.

Please send me information about ILAE activities and other
information of interest to the epilepsy community